Dynavax Technologies Corporation (DVAX) Dividend History

Company News

• Liver Fibrosis Market Is Expected to Reach USD 43.98 Billion By 2030

  The global liver fibrosis market is expected to grow from $17.25 billion in 2021 to $43.98 billion by 2030, driven by the increasing prevalence of liver disorders, adaptation of unhealthy lifestyles, and the rising geriatric population. The North American region dominates the market due to high healthcare expenditure and the presence of major players.

  GlobeNewswire Inc.

  Featured Companies: BMY FGEN GILD JNJ MRK PFE VRTX
• Cancer Vaccines Market Size Expected to Reach USD 30.16 Bn by 2033

  The global cancer vaccines market is expected to grow from $10.21 billion in 2023 to $30.16 billion by 2033, driven by rising cancer incidence and advancements in personalized cancer vaccines. North America and Asia-Pacific are the key regional markets, with the latter expected to witness the fastest growth.

  GlobeNewswire Inc.

  Featured Companies: AMGN MRK
• Dynavax Technologies (DVAX) Q1 2024 Earnings Call Transcript

  DVAX earnings call for the period ending March 31, 2024.

  The Motley Fool
• Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates

  Dynavax Technologies (DVAX) delivered earnings and revenue surprises of -40% and 2.29%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: ATRA
• Myriad Genetics (MYGN) Reports Q1 Loss, Tops Revenue Estimates

  Myriad (MYGN) delivered earnings and revenue surprises of 90.91% and 4.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: MYGN